Geoffrey F. Cox Ph.D., BSc
Director,Novelion Therapeutics Inc.
|Age||Total Calculated Compensation||This person is connected to 134 board members in 7 different organizations across 8 different industries.|
See Board Relationships
As of Fiscal Year 2015
Dr. Geoffrey F. Cox, also known as Geoff, Ph.D., BSc is a Partner at Red Sky Partners LLC. Dr. Cox serves as an Independent Consultant to the Biotechnology and Life Sciences Industry and Principal of Beacon Street Advisors LLC. Dr. Cox served as the Interim Chief Executive Officer of Novelion Therapeutics Inc. (alternate name: QLT Inc.) from October 23, 2014 to November 29, 2016. He has over 35 years of pharmaceutical and biotechnology experience in a broad range of ...
887 Great Northern WayPhone: 604-707-7000
Vancouver, British Columbia V5T 4T5
Board Members Memberships*
Non-Executive Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
University of Birmingham
University of East Anglia
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Severin Schwan Ph.D.||Chief Executive Officer and Executive Director|
Roche Holding AG
|SFr.7.1M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.